151 related articles for article (PubMed ID: 8711177)
1. [Comparison of calcitonin tolerance after intramuscular or intranasal administration in treatment for postmenopausal osteoporosis].
Horst-Sikorska W; Ruszkowska J; Kosowicz J
Przegl Lek; 1996; 53(1):9-11. PubMed ID: 8711177
[TBL] [Abstract][Full Text] [Related]
2. [Clinical efficacy of treatment with salmon calcitonin, administered intranasally for 1 year, in stabilized postmenopausal osteoporosis].
Agnusdei D; Gonnelli S; Camporeale A; Batignani T; Nardi P; Ianes A; Gennari C
Minerva Endocrinol; 1989; 14(3):169-76. PubMed ID: 2695815
[TBL] [Abstract][Full Text] [Related]
3. Intranasal complications in women with osteoporosis under treatment with nasal calcitonin spray: case reports and review of the literature.
Chatziavramidis A; Mantsopoulos K; Gennadiou D; Sidiras T
Auris Nasus Larynx; 2008 Sep; 35(3):417-22. PubMed ID: 18053666
[TBL] [Abstract][Full Text] [Related]
4. [Treatment of ovariectomized patients with intramuscular and nasal-spray synthetic calcitonin].
Zara C; Perotti F; Ferraro R; Lauri A; Saviotti C; Montrasio MG; Caprotti M; Polatti F
Minerva Endocrinol; 1989; 14(1):53-6. PubMed ID: 2733647
[TBL] [Abstract][Full Text] [Related]
5. Randomized, double-blind, clinically controlled trial of intranasal calcitonin treatment in patients with hip fracture.
Huusko TM; Karppi P; Kautiainen H; Suominen H; Avikainen V; Sulkava R
Calcif Tissue Int; 2002 Dec; 71(6):478-84. PubMed ID: 12370798
[TBL] [Abstract][Full Text] [Related]
6. Salmon calcitonin: state of the art in prevention of postmenopausal bone loss?
Reginster JY; Deroisy R; Denis D; Lecart MP; Franchimont P
Acta Belg Med Phys; 1989; 12(2):41-6. PubMed ID: 2690544
[No Abstract] [Full Text] [Related]
7. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 9. Calcitonin in the treatment of osteoporosis.
Siminoski K; Josse RG
CMAJ; 1996 Oct; 155(7):962-5. PubMed ID: 8837547
[TBL] [Abstract][Full Text] [Related]
8. Assessment of the biological effectiveness of nasal synthetic salmon calcitonin (SSCT) by comparison with intramuscular (i.m.) or placebo injection in normal subjects.
Reginster JY; Denis D; Albert A; Franchimont P
Bone Miner; 1987 Apr; 2(2):133-40. PubMed ID: 3504725
[TBL] [Abstract][Full Text] [Related]
9. Calcitonin and the treatment of osteoporosis.
Schneyer CR
Md Med J; 1991 Jun; 40(6):469-73. PubMed ID: 1861574
[TBL] [Abstract][Full Text] [Related]
10. [Quality of life of patients suffering from osteoporosis treated with alendronate and salmon calcitonin].
Sapuła RA; Ostrowski T; Bojar I
Wiad Lek; 2002; 55 Suppl 1():444-7. PubMed ID: 15002282
[TBL] [Abstract][Full Text] [Related]
11. The effect of different doses of calcitonin on bone mineral density and fracture risk in postmenopausal osteoporosis.
Hizmetli S; Elden H; Kaptanoglu E; Nacitarhan V; Kocagil S
Int J Clin Pract; 1998 Oct; 52(7):453-5. PubMed ID: 10622084
[TBL] [Abstract][Full Text] [Related]
12. Use of calcitonin in 20 patients suffering from postmenopausal osteoporosis. A proposal for a therapeutical scheme.
Lanciani P; Porzio V; Cattani D
Panminerva Med; 1991; 33(2):119-20. PubMed ID: 1923555
[TBL] [Abstract][Full Text] [Related]
13. [Long-term local tolerability to intranasally administered salmon calcitonin in post-menopausal osteoporosis].
Gariboldi LM; Bolla I; Baroni MC; Delsignore R; Passeri M; Barberis F
Minerva Med; 1992 Dec; 83(12):827-31. PubMed ID: 1491763
[TBL] [Abstract][Full Text] [Related]
14. Calcitonin.
Silverman SL
Rheum Dis Clin North Am; 2001 Feb; 27(1):187-96. PubMed ID: 11285994
[TBL] [Abstract][Full Text] [Related]
15. [Randomized comparative study using carbocalcitonin i.m. vs carbocalcitonin nasal spray vs ipriflavone x os in the treatment of post-menopausal osteoporosis].
Lobianco R; Merola B; Lupoli G; Cocca A; Guarino M; Pia M; Guerriero S; Lombardi G
Minerva Endocrinol; 1992; 17(2):79-84. PubMed ID: 1296148
[TBL] [Abstract][Full Text] [Related]
16. [Comparison of the effectiveness of 17-beta-estradiol and calcitonin in women with postmenopausal bone loss].
Stĕpán J; Formánková J; Masatová A; Michalský M; Rosenová Z
Cas Lek Cesk; 1997 Apr; 136(8):242-8. PubMed ID: 9264868
[TBL] [Abstract][Full Text] [Related]
17. The effect of calcitonin on biochemical markers and zinc excretion in postmenopausal osteoporosis.
Colpan L; Gur A; Cevik R; Nas K; Sarac AJ
Maturitas; 2005 Jul; 51(3):246-53. PubMed ID: 15978968
[TBL] [Abstract][Full Text] [Related]
18. [Early therapy of osteoporosis with (1-38) parathyroid hormone and calcitonin nasal spray].
Hesch RD; Rittinghaus EF; Harms HM; Delling G
Med Klin (Munich); 1989 Oct; 84(10):488-98. PubMed ID: 2685534
[No Abstract] [Full Text] [Related]
19. Analgesic effect of intranasal and intramuscular salmon calcitonin in post-menopausal osteoporosis: a double-blind, double-placebo study.
Pontiroli AE; Pajetta E; Scaglia L; Rubinacci A; Resmini G; Arrigoni M; Pozza G
Aging (Milano); 1994 Dec; 6(6):459-63. PubMed ID: 7748920
[TBL] [Abstract][Full Text] [Related]
20. Comparison of zinc excretion and biochemical markers of bone remodelling in the assessment of the effects of alendronate and calcitonin on bone in postmenopausal osteoporosis.
Gur A; Colpan L; Cevik R; Nas K; Jale Sarac A
Clin Biochem; 2005 Jan; 38(1):66-72. PubMed ID: 15607319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
